Steroid and Xenobiotic Receptor (SXR) Is a Key System for the Acquisition of Cisplatin Resistance in Endometrial Cancer Cells

Author： Takami N   Sakamoto H   Yamamoto T  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.31, Iss.2, 2003-03, pp. : 59-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies to Overcome Drug Resistance of Receptor Tyrosine Kinaseaddicted Cancer Cells

By  

Current Medicinal Chemistry, Vol. 21, Iss. 14, 2014-05 ,pp. : 1607-1617

Bentham Science Publishers

Access to resources Recommend Favorite

“Metabolic Reprogramming” in Ovarian Cancer Cells Resistant to Cisplatin

By  

Current Cancer Drug Targets, Vol. 11, Iss. 2, 2011-02 ,pp. : 226-235

Bentham Science Publishers

Access to resources Recommend Favorite

Steroid receptor coactivator-3 as a potential molecular target for cancer therapy

By Tien Jean Ching-Yi   Xu Jianming  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1085-1096

Informa Healthcare

Access to resources Recommend Favorite

PET Imaging of Steroid Receptor Expression in Breast and Prostate Cancer

By  

Current Pharmaceutical Design, Vol. 14, Iss. 28, 2008-10 ,pp. : 3020-3032

Bentham Science Publishers

Access to resources Recommend Favorite

ABCG2: the key to chemoresistance in cancer stem cells?

By An Yi   Ongkeko Weg M  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1529-1542

Informa Healthcare

Access to resources Recommend Favorite